ArticleJournal of neuro-oncology2018

Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status.

Eric M Thompson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.